Havemeyer Foundati<strong>on</strong> M<strong>on</strong>ograph Series No. 3METABOLIC ACTIVITY OF <strong>EQUINE</strong> BLASTOCYSTSCRYOPRESERVED IN ETHYLENE GLYCOL ANDGALACTOSEM. K. O’D<strong>on</strong>ovan, N. Oberstein, J. E. Bruemmer, M. Lane*, G. E. Seidel, Jr.,D. K. Gardner* and E. L. SquiresAnimal Reproducti<strong>on</strong> and Biotechnology Laboratory, Colorado State University, Fort Collins, Colorado80523, USA; * Colorado Center for Reproductive Medicine, Englewood, Colorado 80110, USAINTRODUCTIONThe inability <str<strong>on</strong>g>of</str<strong>on</strong>g> expanded equine blastocysts tosurvive standard cryopreservati<strong>on</strong> protocols is welldocumented (Yamamoto et al. 1982; Squires et al.1989; Young et al. 1997). The objective <str<strong>on</strong>g>of</str<strong>on</strong>g> thisstudy was to compare <str<strong>on</strong>g>the</str<strong>on</strong>g> efficacy <str<strong>on</strong>g>of</str<strong>on</strong>g> 3 protocolsfor cryopreserving equine embryos 300–600 Fm indiameter. It was hypo<str<strong>on</strong>g>the</str<strong>on</strong>g>sised that exposingexpanded equine blastocysts to galactose andethylene glycol at various c<strong>on</strong>centrati<strong>on</strong>s for 40min would allow proper equilibrati<strong>on</strong> to occurprior to cryopreservati<strong>on</strong>, thus improving postthaw survival.MATERIALS AND METHODSMorphological Grade 1 or 2 embryos recovered <strong>on</strong>Day 7 post ovulati<strong>on</strong>, between 300–600 Fm indiameter were randomly assigned to <strong>on</strong>e <str<strong>on</strong>g>of</str<strong>on</strong>g> 3cryoprotectant treatments: 1) (n=8) 0.3 Mgalactose (10 min), 2.0 M ethylene glycol (EG) +0.3 M galactose (40 min); 2) (n=5) 0.3 M galactose(10 min), 2.0 M EG + 0.3 M galactose (15 min),and 4.5 M EG + 0.3 M galactose (25 min); or 3)(n=8) 0.3 M galactose (10 min), 2.0 M EG + 0.3 Mgalactose (10 min), 4.5 M EG + 0.3 M galactose(15 min), 2.0 M EG + 0.8 M galactose (10 min).All embryos were loaded into 0.25 ml straws andcooled to -6°C at 4°C/min, held 5 min, seeded,cooled to -35°C at 0.5°C/min and plunged intoliquid nitrogen. Embryos were thawed in air (15 s)followed by a 37°C water bath (15 s). Up<strong>on</strong>thawing, cryoprotectants were removed in 3 or 4steps based <strong>on</strong> <str<strong>on</strong>g>the</str<strong>on</strong>g> specific treatment. Viability wasassessed following <str<strong>on</strong>g>the</str<strong>on</strong>g> freeze/thaw procedure bygrading <str<strong>on</strong>g>the</str<strong>on</strong>g> embryos and recording changes indiameter over time. Additi<strong>on</strong>ally, metabolicactivity <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> embryos pre-freeze and post thawwas compared. Measurements <str<strong>on</strong>g>of</str<strong>on</strong>g> glucose andpyruvate uptake and producti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> lactate wereanalysed using micr<str<strong>on</strong>g>of</str<strong>on</strong>g>luorescence assays (Gardneret al. 1996). Embryos were stained after <str<strong>on</strong>g>the</str<strong>on</strong>g> lastmetabolic assay using Hoechst 33342 (10 µg/ml)and propidium iodide (10 µg/ml) to determinepercent live cells.RESULTSTwenty-<strong>on</strong>e embryos were randomly assigned to<strong>on</strong>e <str<strong>on</strong>g>of</str<strong>on</strong>g> 3 treatments, n 1 =8, n 2 =5, n 3 =8. Meandiameters <str<strong>on</strong>g>of</str<strong>on</strong>g> embryos were not different am<strong>on</strong>gtreatments (P>0.1) but varied within treatmentover time (P
Equine Embryo TransferTABLE 1: Mean diameters and morphological scores (± sd) by timeEndpoint Treatment Initial Thaw Post thaw Post Post IVCassay IVC assayDiameter (Fm) 1 (n=8) 407 a 294 b 247 b 330 a,b 345 a(±90) (±123) (±80) (±113) (±109)2 (n=5) 410 a 279 b 275 b * 295 b * 302 b *(±97) (±80) (±35) (±64) (±81)3 (n=8) 369 a 303 a,b 250 b,c 216 c 198 c(±49) (±56) (±56) (±27) (±45)Grade(1-4) 1 (n=8) 1.3 a 3.4 b 3.4 b 3.1 b 2.9 b(±.27) (±.23) (±.34) (±.74) (±.88)2 (n=5) 1.2 a 3.6 b 3.5 b * 3.6 b,A * 3.7 b,A *(±.45) (±.42) (±.35) (±.89) (±.67)3 (n=8) 1.4 a 3.3 b 3.8 c 4 c,A 4 c,A(±.35) (±.26) (±.38) (± 0) (± 0)a,b,c Means without comm<strong>on</strong> superscript within rows differ (P0.1)Embryos were pooled across treatments int<strong>on</strong><strong>on</strong>viable (Grade 3 to 4, 5 to 25% live cells) andviable (Grade 2.5 or better, 90% live cells) groups.There was no significant difference in post-thawmetabolic parameters between viable (n=5) andn<strong>on</strong>viable (n=16) embryos (Table 3).DISCUSSIONIn <str<strong>on</strong>g>the</str<strong>on</strong>g> current investigati<strong>on</strong>, treatment <strong>on</strong>e (lowmolar ethylene glycol) was more effective incryopreserving large equine embryos thanTreatments 2 (high molar ethylene glycol) and 3(step-down equilibrati<strong>on</strong>). Embryos in treatment<strong>on</strong>e had significantly better final morphologicalgrades and a higher percentage <str<strong>on</strong>g>of</str<strong>on</strong>g> live cells.Additi<strong>on</strong>ally, embryos in Treatment 1 had lesschange in metabolic activity pre-freeze to postthawthan embryos in o<str<strong>on</strong>g>the</str<strong>on</strong>g>r treatments, although<str<strong>on</strong>g>the</str<strong>on</strong>g> difference between treatments was notsignificant (P>0.1). Expanded equine blastocystsexposed to 2 M ethylene glycol for 40 minsurvived cryopreservati<strong>on</strong>.Three embryos from Treatment 2 werefractured up<strong>on</strong> thaw and degenerated in <str<strong>on</strong>g>the</str<strong>on</strong>g> postthaw metabolic assay. C<strong>on</strong>ceivably, embryos58